mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |